Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Carl Allen (1)

National Cancer Institute (NCI) (1)

Collaborator

Baylor College of Medicine (1)

Genentech, Inc. (1)

North American Consortium for Histiocytosis (1)

Study Documents

Intervention Type

drug (2)

other (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

juvenile xanthogranuloma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting

Advanced Malignant Solid Neoplasm
+44 more

Biopsy
+23 more

Birmingham, Alabama
+166 more

Feb 2, 2023

Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease Trial in Memphis, Houston (Cobimetinib)

Recruiting

Langerhan's Cell Histiocytosis
+6 more

Cobimetinib

Phoenix, Arizona
+6 more

Jan 12, 2023